These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29638)

  • 1. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1445-54. PubMed ID: 29638
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1455-61. PubMed ID: 29639
    [No Abstract]   [Full Text] [Related]  

  • 3. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.
    Weiland GA; Minneman KP; Molinoff PB
    Nature; 1979 Sep; 281(5727):114-7. PubMed ID: 38405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine and guanine nucleotide activation of skeletal muscle adenylate cyclase.
    Nambi P; Drummond GI
    Biochim Biophys Acta; 1979 Mar; 583(3):287-94. PubMed ID: 36171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of beta-adrenergic agonist binding by guanylnucleotides in avian erythrocytes.
    Simpson IA; Pfeuffer T
    FEBS Lett; 1980 Jun; 115(1):113-7. PubMed ID: 6248374
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic receptors and adenylate cyclase activity in rat reticulocytes and mature erythrocytes.
    Beckman BS; Hollenberg MD
    Biochem Pharmacol; 1979; 28(2):239-48. PubMed ID: 218589
    [No Abstract]   [Full Text] [Related]  

  • 7. Turn on and turn off reactions of beta-adrenergic-sensitive adenylate cyclase in control and desensitized C6 glioma cells.
    Homburger V; Lucas M; Bockaert J
    FEBS Lett; 1982 May; 141(2):245-50. PubMed ID: 6124458
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane.
    Smith PB; Grefrath SP; Appel SH
    Exp Neurol; 1978 May; 59(3):361-71. PubMed ID: 206455
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of turkey erythrocyte adenylate cyclase by two receptors: adenosine and catecholamines.
    Sevilla N; Tolkovsky AM; Levitzki A
    FEBS Lett; 1977 Sep; 81(2):339-41. PubMed ID: 200475
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenylate cyclase activation by the beta-adrenergic receptors as a diffusion-controlled process.
    Hanski E; Rimon G; Levitzki A
    Biochemistry; 1979 Mar; 18(5):846-53. PubMed ID: 217426
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the influence of N-isopropyl and N-tert butyl substituents on the affinity of ligands for sinoatrial beta-adrenoceptors in rat atria and beta-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle.
    Kaumann AJ; Morris TH; Birnbaumer L
    Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):1-8. PubMed ID: 39258
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and regulation of beta-adrenergic receptors.
    Lefkowitz RJ
    Adv Exp Med Biol; 1978; 96():137-60. PubMed ID: 24993
    [No Abstract]   [Full Text] [Related]  

  • 13. A high affinity agonist . beta-adrenergic receptor complex is an intermediate for catecholamine stimulation of adenylate cyclase in turkey and frog erythrocyte membranes.
    Stadel JM; DeLean A; Lefkowitz RJ
    J Biol Chem; 1980 Feb; 255(4):1436-41. PubMed ID: 6243637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydroxybenzylpindolol--activation mechanism of adenylate cyclase and beta-adrenergic receptor].
    Yamamura H
    Nihon Rinsho; 1976; 34(3):534-9. PubMed ID: 6811
    [No Abstract]   [Full Text] [Related]  

  • 15. Reconstitution of catecholamine-sensitive adenylate cyclase activity: interactions of solubilized components with receptor-replete membranes.
    Ross EM; Gilman AG
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3715-9. PubMed ID: 198799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow GDP dissociation from the guanyl nucleotide site of turkey erythrocyte membranes is not the rate limiting step in the activation of adenylate cylase by beta-adrenergic receptors.
    Levitzki A
    FEBS Lett; 1980 Jun; 115(1):9-10. PubMed ID: 6248377
    [No Abstract]   [Full Text] [Related]  

  • 18. Agonist-induced increase in apparent beta-adrenergic receptor size.
    Limbird LE; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):228-32. PubMed ID: 24213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of beta-adrenergic receptor-coupled adenylate cyclase: implications of a redox mechanism for the action of agonists at beta-adrenergic receptors.
    Wong A; Hwang SM; Cheng HY; Crooke ST
    Mol Pharmacol; 1987 Apr; 31(4):368-76. PubMed ID: 2883567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the beta-adrenergic receptor and adenylate cyclase in skeletal muscle plasma membranes.
    Grefrath ST; Smith PB; Appel SH
    Arch Biochem Biophys; 1978 Jun; 188(2):328-37. PubMed ID: 209751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.